CIRENCESTER, England, May 2, 2024
/PRNewswire/ -- Corin Group, a pioneer in orthopaedic innovation,
today announced the successful completion of first cases using the
Apollo™ platform and ApolloKnee™ software for robotic-assisted
total knee arthroplasty.
First user, Dr Jeff Lawrence of
Wisconsin, USA said, "With Apollo,
I can consistently achieve a personalized, dynamic balance of the
knee and with fewer soft-tissue releases. Clinically, this results
in less pain, better function, and improved outcomes for my
patients. I have also been quite impressed by the new ApolloKnee
workflow, which features efficient gesture-controls and autonomous
planning. I'm very excited by the experience from my first
cases and look forward to bringing this technology to all my
patients in the future."
Apollo empowers surgeons throughout the arthroplasty procedure
with tools to create and precisely implement a personalized
surgical plan for each patient. Surgeons can learn from past
procedures by reviewing data from before and during surgery
alongside patient reported outcomes.
"ApolloKnee is the only procedure capable of providing a
force-controlled, robotic assessment of the knee throughout the
full range of motion and before committing to any bony cuts,"
explained Dr Jim Pierrepont, Global Franchise Lead at Corin
Group
Additional features of the system include autonomous planning
tailored to the surgeon's preferences and alignment philosophy,
gesture-controlled workflow, and a robotic cutting guide for the
precise implementation of femoral and tibial cuts. The Apollo
station is an elegant and compact system designed to support
multiple surgical applications and a streamline, wireless
integration to CorinConnect™ for seamless follow-up, clinical
research, and continuous learning.
Jon Serbousek, CEO of Corin Group
and Senior Advisor to parent company Permira, expressed, "This is a
proud moment for Corin, the realization of our vision to bring
personalized dynamic balance to patients around the world. We look
forward to sharing additional information in the coming weeks as
the first Apollo patients reach new milestones in their joint
replacement journey."
The Apollo platform and ApolloKnee software application have
United States FDA 510(k) clearance and EU MDR approval.
Corin Group is a fast-growing global company with a
vision to advance orthopaedics. The unique combination of advanced
technologies and clinically proven implants is intended to deliver
improved outcomes and maximize healthcare value for patients,
surgeons, and healthcare providers. For more information please
visit www.coringroup.com and follow us on LinkedIn.
Media inquiries: media@coringroup.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/corin-group-announces-clinical-use-of-apollo-robotic-assisted-surgical-platform-302133873.html
SOURCE Corin Group